Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Nova Stream

 

Investor launches buyout of Nigeria’s third-largest diagnostics chain

Listed Nigerian lab and imaging group Union Diagnostics, the country's third-largest by revenue, is the target of a majority buyout by its largest single shareholder. We talk to a well-placed source about the Nigerian diagnostics market which has five big players, including European and GCC diagnostic operators Synlab, IDH and Cerba which entered recently. 
March 25, 2020

Divestment and delayed repayments: How NMC might survive

Is NMC Health a sinking ship, or might it still be saved? HBI speaks to a UAE-based operator to find out how the under-fire group might keep its head above water, the difficult steps it must take to stay afloat, and who conceivably might step in to bail it out.
March 18, 2020

Interview: Shirley Ryan AbilityLab

Shirley Ryan AbilityLab, formerly the Rehabilitation Institute of Chicago, claims to be the largest rehabilitation hospital in the USA, and works with groups from Bulgaria to UAE. HBI talk to Kelly Cox Watkins, Vice President, Market Development and Barry Fleischer, Executive Director, Advisory Services, about how to build a successful rehabilitation service, their groups' focus on patient ability, not adapting to disability and what that means in practice, and about its advisory work.
March 16, 2020

Scandal hit NMC uncovers $2.7bn hidden debt used for unknown purposes

In the latest in a long line of scandalous revelations to hit the UAE's largest for-profit healthcare provider, NMC Health has revealed it has uncovered $2.7bn of debt which was hidden from its board, and used for unknown purposes - bringing its borrowings to a whopping $5bn.
March 12, 2020

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.
March 5, 2020

Investors for Health opens door to all serious emerging market investors

All emerging market health-care investors are welcome to join Investors for Health (I4H), a newish community of 30+ investors including development banks, private equity, venture capital and impact funds. The group aims to jointly focus on private healthcare development in emerging markets with a focus on equity and alignment with universal healthcare cover. It next meets at HBI 2020, April 20-22, London. Its formation reflects a quiet revolution in the role of for-profit healthcare and its importance in bridging the World Health Organisation's estimated $686bn funding gap in low-and-middle-income countries to achieve the United Nation’s Sustainable Development Goal #3 (“Ensure healthy lives and promote well-being for all at all ages”).
March 4, 2020

SRL shifts focus to B2C as minority sale stalls

Fortis-owned Indian lab chain SRL says that after the last two years of "stagnant expansion" it has started to open more blood collection points in a shift to the B2C segment. The company remains tight-lipped about the ongoing minority sale process.
February 28, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us